Eppendorf BioBLU
Hamburg, Germany
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (4)
○ EMA GMP
○ MHRA GMP
Quick Facts: Eppendorf BioBLU
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Hamburg, Germany
- Modalities
- Single-Use Bioreactor Equipment, Bioprocess Equipment (R&D through Commercial), Cell Culture (mammalian, insect, stem cell), Microbial Fermentation, AAV production support, mRNA/pDNA production support
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Eppendorf BioBLU
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSingle-Use Bioreactor Equipment, Bioprocess Equipment (R&D through Commercial), Cell Culture (mammalian, insect, stem cell), Microbial Fermentation, AAV production support, mRNA/pDNA production support
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press4 articles
Broad modality coverage (6 modalities)
Recent News 4 articles
HEK293 Suspension Cell Culture Using The BioFlo 320 Bioprocess Controller With BioBLU 3c Single-Use Bioreactors - Bioprocess Online
Application of Raman Spectroscopy and Univariate Modelling As a Process Analytical Technology for Cell Therapy Bioprocessing - Frontiers
Transient Lentiviral Vector Production In HEK 293T Cells Using The BioFlo 320 Control Station With A BioBLU 5p Single-Use Packed-Bed Vessel - Bioprocess Online
Stem Cell Therapy Development Embraces New Technologies - Genetic Engineering and Biotechnology News
Frequently Asked Questions About Eppendorf BioBLU
What is Eppendorf BioBLU's CDMO Signal Score?
Eppendorf BioBLU has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Eppendorf BioBLU for a manufacturing program?
Use the free AI matchmaker to compare Eppendorf BioBLU against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Cytovance Biologics
Oklahoma City, OK
Signal Score: 61.5
Microbial Fermentation, Biologics, Recombinant Proteins, Mammalian Cell Culture, Plasmid DNA
Olon Group
Rodano (Milan), Italy
Small Molecule API, HPAPI / Cytotoxics, Microbial Fermentation, Mammalian Cell Culture, Recombinant Proteins / Enzymes, Biologics (mAbs), ADC (end-to-end bioconjugation), Oligonucleotide / Peptide, Chemical Synthesis, Semi-Synthesis